CX717 in the Treatment of Adult ADHD

Clinical trial NCT03375021 · COMPLETED

Trial details

NCT number: NCT03375021
Sponsor: RespireRx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2005-07-19
Primary completion: 2006-01-10
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.